QDEL - Quidel more quick diagnosis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QDEL - Quidel more quick diagnosis

QDEL 27.34

-1.4%

10:26 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Arthur Radley	9/1/2009 3:03:39 PM
	of 1693

Sidoti Starts Quidel (QDEL) at Buy, $21 Price Target 11:27 am ET 09/01/2009- StreetInsider Sidoti & Co. initiates coverage on Quidel Corp. (Nasdaq: QDEL) with a Buy rating and a $21 price target. Click here to see all the analyst upgrades/downgrades on shares of Quidel. Quidel Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of point-of-care (POC) diagnostic solutions for infectious diseases, and reproductive and women's health.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next